Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eniac Ventures is a seed-stage venture capital firm that invests primarily in technology startups rather than operating as a drug developer, healthcare provider, or life sciences company. The firm is best known for leading seed rounds and supporting founders in areas such as product-market fit, hiring, go-to-market strategy, and company building. Its investment focus spans software, artificial intelligence, fintech, deep tech, consumer, SaaS, and selected healthcare and biotechnology companies within its portfolio. Eniac Ventures was founded in 2009 and is headquartered in New York. For biotech or healthcare analysis purposes, it is best classified as an investor with occasional exposure to healthcare and biotech companies, not as a therapeutic pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eniac Ventures.